The S100B protein binds with strong affinity to the V-domain of the RAGE receptor. It can be used as both an adjunct marker, to support diagnoses of brain damage alongside other clinical evidence, and as a prognostic marker, because its levels directly correlate with the severity, progression, and outcome of several neurological disorders.